Tower Research Capital LLC (Trc) Cure Vac N.V. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cure Vac N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,779 shares of CVAC stock, worth $16,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,779
Previous 5,770
0.16%
Holding current value
$16,701
Previous $16,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CVAC
# of Institutions
86Shares Held
10.5MCall Options Held
75.5KPut Options Held
33.5K-
Black Rock Inc. New York, NY2.25MShares$6.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$4.76 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$4.53 Million10.6% of portfolio
-
Ubs Group Ag577KShares$1.67 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.45 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $542M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...